Results 81 to 90 of about 15,167 (190)
Pregnancy, Volume 2, Issue 5, September 2026.Abstract Introduction Preeclampsia with severe features remains a major contributor to maternal and neonatal morbidity. In select patients <34 weeks, expectant management may safely prolong pregnancy and improve neonatal outcomes. Oral labetalol and extended‐release nifedipine are commonly used for blood pressure control in this setting; however ...
Ryan Farias, Christopher Ennen
wiley +1 more source
, 2020 Background-In pregnancy to control the severe hypertension situation, there is no record about the safety of intravenous labetalol and hydralazine. Labetalol and hydralazine both have their own disadvantage and advantages.
Muhammad Zulqarnain, Maimoona Shabbir, Muhammad Mubeen Yaseen
core +1 more source
Journal of Medical Case Reports, 2020 Background Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure. Hydralazine can induce antineutrophil cytoplasmic antibody-associated vasculitis due to its auto-immunogenic capability and one of the
Ahmad Al-Abdouh +4 more
doaj +1 more source
Basic &Clinical Pharmacology &Toxicology, Volume 139, Issue 3, September 2026.ABSTRACT Introduction 37%–48% of older patients receive anticholinergic medicines, increasing the risk for falls, delirium, dementia and death. Hospital admission may provide an opportunity for deprescribing to improve outcomes. This study evaluated the feasibility and acceptability of a digital tool to identify anticholinergic medicines and support ...
Kinda Ibrahim +12 more
wiley +1 more source
Comparison Of Fe(II) And Fe(III)-Hydralazine Complexes, A Potentiometric And Spectrophotometric Studa [PDF]
, 2018 Iron in oxidation states (+2 and +3) is very essential element for human body, and its concentration significantly altered in cardio vascular disease.
Iqbal, Muhammad +7 more
core +1 more source
Nature Communications, 2019 Hydralazine is a drug used in the treatment of heart failure and cancer, and it has recently been shown to promote lifespan in C. elegans. Here, the authors elucidate the mechanism of action of hydralazine, and show that it targets PKA to promote ...
Esmaeil Dehghan +4 more
doaj +1 more source
A Challenging Twist in Pulmonary Renal Syndrome
Case Reports in Rheumatology, 2014 Case. We report a rare case of hydralazine-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. A 75-year-old African American woman with history of high blood pressure on hydralazine for 3 years presented with acute onset of shortness of ...
Rajaie Namas +3 more
doaj +1 more source
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
, 2006 Melvin R Echols, Clyde W YancyUniversity of Texas Southwestern Dallas, TX, USAAbstract: Despite significant improvement in therapy and management, heart failure remains a worrisome disease state that is especially problematic in special populations ...
Clyde W Yancy, Melvin R Echols
core
HFrEF pharmacological treatment: hydralazine and isosorbide dinitrate
, 2018 The use of hydralazine and isosorbide dinitrate in combination with renin–angiotensin blockade and evidence-based beta-blocker therapy is an accepted therapy for heart failure with reduced ejection fraction (HFrEF).
Clyde W. Yancy, Faraz S. Ahmad
core +1 more source